Feb 18, 2021 7:00am EST CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares
Feb 11, 2021 11:22pm EST CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares
Feb 08, 2021 7:00am EST CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
Dec 10, 2020 7:00am EST CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications
Dec 01, 2020 7:00am EST CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update
Nov 10, 2020 7:00am EST CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients
Oct 26, 2020 7:00am EDT CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine
Sep 21, 2020 7:00am EDT CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant
Sep 16, 2020 12:00pm EDT CollPlant Biotechnologies Presents on the Use of Novel, Plant-Derived, Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020